日前，在韩国首尔举行的第30届亚太经导管心血管介入治疗大会（TCTAP 2025）上，来自马来西亚的“心苗”访问学者计划结业学员Lim Sumin医师，凭借在厦门大学附属心血管病医院(简称"厦心医院")王焱院长团队培训期间参与的1例高难度病例报告，荣获“The Best Presenter"荣誉。
另一位参会的印度学员Senthilrj Thangasami医师，同样以在厦心医院培训期间的典型病例报告，赢得现场评委的一致赞誉。心苗访问学者在亚太地区介入心血管领域顶尖会议上崭露头角，彰显厦心医院国际专科人才培训项目的丰硕成果。
厦心高难度病例闪耀TCTAP
Sumin医师在TCTAP 2025上展示的是1例下壁心肌梗死伴心源性休克的危重病例。患者急诊行经皮冠状动脉介入治疗(PCI)，并放置了主动脉内球囊反搏(IABP)，情况仍不稳定。超声检查显示二尖瓣和三尖瓣严重反流且两侧乳头肌破裂。此类病例在国际上的死亡率高达70%。厦心医院团队创新性地采用经导管同时修复二尖瓣和三尖瓣的高难度技术，最终使患者转危为安。
“根据评委反馈，这个案例几乎获得了满分评价！”Sumin谦虚地表示，“这不仅因为手术本身的复杂性，更因为厦心团队术前精准的分析判断、术中完善的应急预案和出色的处理能力。说实话，我觉得自己是沾了王焱院长和厦心的光。”
在厦心医院参与“心苗”访问学者计划培训期间，Sumin主要专注于结构性心脏病介入治疗技术的学习。“在马来西亚，这类手术尚未普及，而厦心医院已经建立了成熟且经验丰富的微创治疗体系。”她特别提到，“王焱院长不仅耐心解释每个手术步骤的决策依据，更给予我们宝贵的实践机会。”
谈及参赛案例，Sumin回忆道：“刚开始接触这类手术时，我更多是在观察和记录。回去反复研读笔记后，才能真正理解每个决策的精妙之处。这就像参加大师班，每次都受益良多。
回国后，Sumin运用在厦心医院学习的技术，已成功开展了多例TAVI、BAV、PBMV等结构性心脏病介入手术。“我的目标是让患者不再面临'无计可施'的困境，而是有多种治疗方案可选。”
作为在联合国总部发布并入选国家国际发展合作署“全球发展项目库”的国际培训项目，厦心医院“心苗”访问学者计划自2023年启动以来，已培养了来自12个国家的22名学员。心苗计划的创新实践，为构建人类卫生健康共同体提供了可复制的中国方案。培养一个学员，带动一个团队，影响一个地区，这项计划正在全球范围内播撒心血管诊疗技术发展的种子。
正如Sumin医师所说：“在厦心学到的不仅是技术，更是一种追求卓越的医疗理念。”心苗计划的持续发展，将编织起一张跨越国界的生命守护网络，让优质医疗资源惠及更多患者，真正实现“医无国界，护佑生命”的崇高理想。
Heart Sapling Germinate | Malaysian Scholar Won The Award Of Asia Pacific Top Cardiovascular Academic Conference for Xiamen Cardiovascular Hospital Case
Case Highlight: XMCH's Complex Case Shines at TCTAP
At TCTAP 2025, Dr. Sumin presented a critical case involving an inferior myocardial infarction with cardiogenic shock. The patient underwent emergency percutaneous coronary intervention (PCI) and received intra-aortic balloon pump (IABP) support, yet remained unstable. Echocardiography revealed severe mitral and tricuspid regurgitation with bilateral papillary muscle rupture-a condition with a mortality rate as high as 70% internationally. The XMCH team employed a groundbreaking approach by simultaneously repairing both valves via transcatheter intervention, ultimately saving the patient's life.
"According to the judges, the case nearly received a perfect score!" Dr. Sumin humbly remarked. “It wasn't just the complexity of the procedure-it was the XMCH team's precise preoperative analysis, well-prepared contingency plans during the surgery, and outstanding handling that made the difference. Honestly, I feel I was simply riding on the brilliance of President Wang Yan and the XMCH team."
Transformation: Sharpening Skills through Complex Case Practice
During her participation in the Heart Sapling Visiting Scholar Program at XMCH, Dr. Sumin primarily focused on learning interventional techniques for structural heart diseases. “In Malaysia, these procedures are still not widely practiced, while XMCH has already built a mature and experienced minimally invasive system,”she noted.“President Wang Yan not only patiently explained the rationale behind every surgical step but also gave us invaluable hands-on opportunities.”
Reflecting on the case presented at the conference, she recalled, “When I first encountered such procedures, I mainly observed and took notes. Only after reviewing them repeatedly back home did I truly grasp the intricacies behind each decision. It felt like attending a masterclass-each session was immensely beneficial.”
Returning Home: Sowing Seeds of Hope
Comparing the healthcare systems of the two countries, Dr. Sumin said frankly, “XMCH is equipped with cutting-edge technology, a full-fledged cardiac specialty team, and extensive clinical research. Everyone who visits XMCH is deeply impressed, especially by the world’s first robotic mitral valve clipping surgery. It exceeded my imagination!” She highlighted that China’s advancement in medical robotics and AI applications is “beyond comparison.”
After returning home, Dr. Sumin has successfully applied the techniques learned at XMCH to perform multiple structural heart interventions, including TAVI, BAV, and PBMV procedures. “My goal is to ensure that patients no longer face a dead end, but instead have multiple treatment options.”
As an international training project included in the “Global Development Project Pool” released at the United Nations headquarters by China's International Development Cooperation Agency, Heart Sapling Visiting Scholar Program has, since its launch in 2023, trained 22 scholars from 12 countries. The innovative practices of Heart Sapling Visiting Scholar Program offer a replicable “Chinese solution” for building a shared global community of health. By cultivating one scholar, the program empowers a team and influences a region. This initiative is spreading the seeds of cardiovascular care advancement worldwide. As Dr. Sumin put it: “What I learned at XMCH was not only technical skills but also a mindset of medical excellence.” With continued development, Heart Sapling Visiting Scholar Program is weaving a cross-border safety net for life, bringing quality medical resources to more patients and truly realizing the noble vision of “medicine without borders, safeguarding life”.
转自｜金砖心血管健康创新中心
